$ 12.25

0.00(0%)

05-19 11:48

Daxor Corporation

Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.
最高:12.25今开:12.25成交量:32股换手:0.00%
最低:12.25昨收:12.25成交额:--振幅:0.00%
52周最高:15.46量比:0.01市盈率(TTM):250.38市净率:3.63
52周最低:8.62委比:0.00%市盈率(静):亏损市销率:186.98
每股收益:0.05股息(TTM):--每手股数:1总市值:4941.50万
每股净资产:3.63股息率(TTM):0.33%最小价差:0.01总股本:403.39万
机构持股:--Beta:--空头回补天数:--货币单位:USD
最新获投
暂无数据
最新动态
暂无数据
五力模型
暂无数据
财务指标
暂无数据
暂无数据
单位:美元
2017-12-31
2016-12-31
2015-12-31
2014-12-31
营运资金
-271.39万
172.91万
1,825.04万
-132.08万
+特别项目
--
--
--
--
+营运资金变动
44.68万
-40.81万
9.16万
102.52万
经营现金流
-226.72万
132.10万
1,834.20万
-29.56万
资本支出
--
--
--
--
收购所得净资产
--
--
--
--
固定资产和业务出售收入
--
--
--
--
投资买卖净额
--
--
244.83万
--
其他资金
0.00
0.00
0.00
0.00
投资现金流
--
--
244.83万
--
发放现金股利
-11.21万
-11.40万
-15.41万
-11.98万
股本变动
-24.82万
-43.53万
-86.03万
-69.59万
发行/削减债务净额
153.28万
-104.34万
-1,751.12万
111.13万
其他融资基金
--
--
--
--
筹资现金流
117.25万
-159.27万
-1,852.56万
29.56万
汇率影响
--
--
--
--
现金净流动
-109.46万
-27.17万
226.47万
--
自由现金流
-226.72万
132.10万
1,834.20万
-29.56万
公司高管
Gary Joseph Fischman
Gary Joseph Fischman is Vice President-Research & Development at Daxor Corp. He received a doctorate from Thomas Jefferson University, an undergraduate degree from Hunter College and a doctorate from Temple University School of Podiatric Medicine.
James A. Lombard
James A. Lombard is on the board of Daxor Corp. He previously was Director-Administrative Services Division at The New York City Council and Principal at Citicorp, Inc. He received an undergraduate degree from Iona College and an MBA from The Leonard N Stern School of Business.
Martin S. Wolpoff
Martin S. Wolpoff is on the board of Daxor Corp. He received an undergraduate degree and a graduate degree from City University of New York.
Michael R. Feldschuh
Michael R. Feldschuh founded Aristarc Capital LLC. Presently, he is Chairman, President, CEO & EVP at Daxor Corp. In his past career he was Managing Director & Portfolio Manager at Millennium Partners LLC (New York), Proprietary Trader at Morgan Stanley & Co. LLC, Proprietary Trader at D. E. Shaw Investment Group LLC, Managing Director at Millennium Management LLC and Managing Director at Morgan Stanley Investment Management, Inc. Mr. Feldschuh received an undergraduate degree from Columbia College (MO).
Diane Marie Meegan
Presently, Diane Marie Meegan holds the position of Secretary for Daxor Corp.
Gary Joseph Fischman
Gary Joseph Fischman is Vice President-Research & Development at Daxor Corp. He received a doctorate from Thomas Jefferson University, an undergraduate degree from Hunter College and a doctorate from Temple University School of Podiatric Medicine.
James A. Lombard
James A. Lombard is on the board of Daxor Corp. He previously was Director-Administrative Services Division at The New York City Council and Principal at Citicorp, Inc. He received an undergraduate degree from Iona College and an MBA from The Leonard N Stern School of Business.
Martin S. Wolpoff
Martin S. Wolpoff is on the board of Daxor Corp. He received an undergraduate degree and a graduate degree from City University of New York.
Michael R. Feldschuh
Michael R. Feldschuh founded Aristarc Capital LLC. Presently, he is Chairman, President, CEO & EVP at Daxor Corp. In his past career he was Managing Director & Portfolio Manager at Millennium Partners LLC (New York), Proprietary Trader at Morgan Stanley & Co. LLC, Proprietary Trader at D. E. Shaw Investment Group LLC, Managing Director at Millennium Management LLC and Managing Director at Morgan Stanley Investment Management, Inc. Mr. Feldschuh received an undergraduate degree from Columbia College (MO).
Diane Marie Meegan
Presently, Diane Marie Meegan holds the position of Secretary for Daxor Corp.
高管交易状态
暂无数据
持股状况
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Merrill Lynch & Co Inc
4
--
4
--
2018-06-30
Northern Trust Investments Inc
37
--
--
--
2018-06-30
BlackRock Inc
131
--
--
--
2018-06-30
Deutsche Bank AG
1000
0.02%
1000
--
2018-06-30
UBS Securities LLC
2019
0.05%
1726
589.08%
2018-06-30
Vanguard Group Inc
8705
0.23%
--
--
2018-07-31
Renaissance Technologies Corp
38800
1.04%
-17900
-31.57%
2018-06-30
BlackRock Advisors (UK) Ltd
100
--
100
--
2018-03-31
Morgan Stanley Smith Barney LLC
750
0.02%
750
--
2018-03-31
Wells Fargo Advisors, LLC
1
--
--
--
2017-12-31
BlackRock Fund Advisors
131
0.01%
--
--
2018-03-21
California Public Employees Retrmnt Sys
13700
0.36%
--
--
2017-09-30
Tower Research Capital LLC
733
0.02%
58
8.59%
2017-06-30
Creative Planning Inc
300
0.01%
300
--
2016-09-30
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Vanguard Extended Market Idx Inv
8705
0.23%
--
--
2018-07-31
iShares Core S&P Total US Stock Mkt
131
--
--
--
2018-09-12
Northern Small Cap Core
37
--
--
--
2018-06-30
Vanguard Total Stock Mkt Idx
26132
0.70%
-18362
-41.27%
2018-02-28
Vanguard Balanced Index Inv
3062
0.08%
-1678
-35.40%
2018-02-28
Vanguard Instl Ttl Stk Mkt Idx InstlPls
161
--
--
--
2018-02-28
Vanguard Extended Market Index Fund
8705
0.20%
--
--
2015-09-30
Vanguard Balanced Index Fund
7259
0.20%
--
--
2015-09-30
Vanguard Instl Total Stock Market Index
161
--
--
--
2015-09-30